{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:52:36Z","timestamp":1758819156209},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,5,21]],"date-time":"2003-05-21T00:00:00Z","timestamp":1053475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Industrial Med"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The diagnosis of chronic beryllium disease (CBD) relies on the beryllium lymphocyte proliferation test (BeLPT) to demonstrate a Be specific immune response. This test has improved early diagnosis, but cannot discriminate beryllium sensitization (BeS) from CBD. We previously found high neopterin levels in CBD patients' serum and questioned whether Be\u2010stimulated neopterin production by peripheral blood cells in vitro might be useful in the diagnosis of CBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>CBD, BeS, Be exposed workers without disease (Be\u2010exp) normal controls and sarcoidosis subjects were enrolled. Peripheral blood mononuclear cells (PBMN) were cultured in the presence and absence of beryllium sulfate. Neopterin levels were determined from cell supernatants by enzyme linked immunosorbent assay (ELISA). Clinical evaluation of CBD subjects included chest radiography, pulmonary function testing, exercise testing, and the BeLPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CBD patients produced higher levels of neopterin in both unstimulated and Be\u2010stimulated conditions compared to all other subjects (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Unstimulated neopterin mononuclear cell levels overlapped among groups, however, Be\u2010stimulated neopterin levels in CBD showed little overlap. Using a neopterin concentration of 2.5 ng\/ml as a cutoff, Be\u2010stimulated neopterin had a sensitivity of 80% and specificity of 100% for CBD and was able to differentiate CBD from BeS. Be\u2010stimulated neopterin was inversely related to measures of pulmonary function, exercise capacity, and gas exchange.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Neopterin may be a useful diagnostic adjunct in the non\u2010invasive assessment of CBD, differentiating CBD from BeS. Further studies will be required to determine how it performs in workplace screening. Am. J. Ind. Med. 43:592\u2013601, 2003. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ajim.10227","type":"journal-article","created":{"date-parts":[[2003,5,21]],"date-time":"2003-05-21T21:00:47Z","timestamp":1053550847000},"page":"592-601","source":"Crossref","is-referenced-by-count":12,"title":["Beryllium\u2010stimulated neopterin as a diagnostic adjunct in chronic beryllium disease"],"prefix":"10.1002","volume":"43","author":[{"given":"Lisa A.","family":"Maier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Kittle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Mroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee S.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,5,21]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050067"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"e_1_2_1_4_1","first-page":"25","article-title":"Relationship between serum neopterin and lymphocytic alveolitis in sarcoidosis","volume":"5","author":"Blaschke E","year":"1988","journal-title":"Sarcoidosis"},{"key":"e_1_2_1_5_1","first-page":"185","article-title":"Standardized single breath normal values for carbon monoxide diffusing capacity","volume":"123","author":"Crapo RO","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02713657"},{"key":"e_1_2_1_7_1","first-page":"232","article-title":"Chronic nonspecific respiratory disease, Berlin, New Hampshire, 1961\u20131967: A cross\u2010sectional study","volume":"104","author":"Ferris BG","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_8_1","first-page":"457","article-title":"Respiratory function tests: Normal values at medium altitudes and the prediction of normal results","volume":"79","author":"Goldman HI","year":"1959","journal-title":"Am Rev Tuber"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1999.tb00367.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0274(199707)32:1<21::AID-AJIM3>3.0.CO;2-U"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004200100237"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.130.3.1047","article-title":"Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants","volume":"130","author":"Huber C","year":"1983","journal-title":"J Immunol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.160.1.310"},{"key":"e_1_2_1_14_1","first-page":"175","article-title":"Neopterin as a marker for cell\u2010mediated immunity in patients with pulmonary tuberculosis","volume":"1","author":"Immanuel C","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_1_15_1","volume-title":"Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconioses Geneva","author":"International Labor Organization","year":"1980"},{"key":"e_1_2_1_16_1","first-page":"267","article-title":"Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure\u2010disease relations","volume":"35","author":"Kreiss K","year":"1993","journal-title":"J Occup Med"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.6.1474"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.11.743"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/104732201750169570"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.4.9806106"},{"key":"e_1_2_1_23_1","first-page":"A731","article-title":"Neopterin and IFN\u2010\u03b3 as diagnostic adjuncts in chronic beryllium disease","volume":"161","author":"Maier L","year":"2000","journal-title":"Am J Resp Crit Care Med"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17304030"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.3.776"},{"key":"e_1_2_1_26_1","first-page":"154","volume-title":"Clinical pulmonary function testing: A manual of uniform laboratory procedures","author":"Morris AH","year":"1984"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90300-D"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.1.8025739"},{"key":"e_1_2_1_29_1","first-page":"A145","article-title":"Rate of progression from beryllium sensitization to chronic beryllium disease is 9\u201319% per year","volume":"157","author":"Newman LS","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-200103000-00011"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103402"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.3.661"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(88)90065-4"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(96)03378-1"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.6.9610040"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL\u20102 and IFN\u2010gamma in berylliosis","volume":"158","author":"Tinkle SS","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_1_37_1","first-page":"392","article-title":"In\u2010vitro and in\u2010vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens, and lipopolysaccharide (LPS)","volume":"74","author":"Troppmair J","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_38_1","first-page":"696","article-title":"Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy","volume":"135","author":"Watters LC","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00910.x"},{"key":"e_1_2_1_40_1","first-page":"2863","article-title":"Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP\u20101) upon cytokine treatment","volume":"50","author":"Werner\u2010Felmayer G","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.1.74"},{"key":"e_1_2_1_42_1","first-page":"729","article-title":"Neopterin and interferon gamma serum levels in patients with heart and kidney transplants","volume":"24","author":"Woloszczuk W","year":"1986","journal-title":"J Clin Chem Clin Biochem"}],"container-title":["American Journal of Industrial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajim.10227","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajim.10227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:07:20Z","timestamp":1700240840000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajim.10227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,21]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1002\/ajim.10227"],"URL":"https:\/\/doi.org\/10.1002\/ajim.10227","archive":["Portico"],"relation":{},"ISSN":["0271-3586","1097-0274"],"issn-type":[{"value":"0271-3586","type":"print"},{"value":"1097-0274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,21]]}}}